13F Filings History of GILEAD SCIENCES, INC.

Latest 13F report: Q4 2025 - 12 Feb 2026
Value $: $1,935,507,854
Signature - Title: Andrew D. Dickinson - Executive Vice President and Chief Financial Officer
Location: Foster City, CA
Summary: This page shows a list of all the recent 13F filings made by GILEAD SCIENCES, INC.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. GILEAD SCIENCES, INC. reported 6 stock holdings with total value $1,935,507,854 as of Q4 2025. Top holdings included RCUS, GLPG, ACLX, ASMB, and KYTX.

Notify me when GILEAD SCIENCES, INC. files a new 13F portfolio report.

Holdings Value

Quarter	Holdings	Value $	Bought	Sold	Net	Top Holdings	Form Type	Filing Time
Q4 2025	6	$1,935,507,854	$0	-$85,797,631	-$85,797,631	RCUS, GLPG, ACLX, ASMB, KYTX	13F-HR	12 Feb 2026, 16:36
Q3 2025	9	$1,791,467,184	+$58,775,552	-$5,069,444	+$53,706,108	GLPG, ACLX, RCUS, ASMB, MRUS	13F-HR	13 Nov 2025, 16:44
Q2 2025	14	$1,280,204,668	$0	-$2,420,378	-$2,420,378	GLPG, ACLX, RCUS, ASMB, TNGX	13F-HR	14 Aug 2025, 10:58
Q1 2025	14	$1,181,331,731	+$16,512,425	-$9,131,340	+$7,381,085	ACLX, GLPG, RCUS, ASMB, MRUS	13F-HR	13 May 2025, 16:15
Q4 2024	16	$1,551,148,266	$0	$0	$0	ACLX, GLPG, RCUS, ASMB, MRUS	13F-HR	13 Feb 2025, 16:14